Skip to content
Snippets Groups Projects
Commit fe46b914 authored by Aadityanshu Abhinav's avatar Aadityanshu Abhinav
Browse files

Updated model.html to add Future Directions subheading and content

parent 1bbb3d71
No related branches found
No related tags found
1 merge request!48Updated model.html to add Future Directions subheading and content
......@@ -184,7 +184,7 @@ endblock %}
<img src="https://static.igem.wiki/teams/4931/wiki/modalimg20.png" alt="" />
<br>
<div class="model-subheading2">
<h3>Results</h3>
<h3>Simulations</h3>
</div>
<br>
<p>
......@@ -203,6 +203,13 @@ endblock %}
<br>
<img src="https://static.igem.wiki/teams/4931/wiki/modalimg24.png" alt="" />
<br>
<div class="model-subheading2">
<h3>Future Directions</h3>
</div>
<br>
<p>
One of the greatest hurdles of engineered therapeutic mechanisms is integrating an efficient solution into a living organism in all its complexity, with minimal loss of product function. In our approach to resolving homocystinuria, it is to be noted that the approach is not to maximize the production of the required enzymes but to keep it, and other metabolites at optimum levels. Achieving this level of finesse in modulating enzyme activity while minimizing perturbations to other integral systems is a direct application of our RBS design tools. Using an array of RBS sequences characterized by expression levels and the predictor optimizer tool, we are able to easily add additional features like kill–switches, whose core toxin-antitoxin system requires fine control over expression activity.
</p>
</div>
{% endblock %}
0% Loading or .
You are about to add 0 people to the discussion. Proceed with caution.
Finish editing this message first!
Please register or to comment